Kanemi Co., Ltd.

As of August 31, 2024, Kanemi Co., Ltd. carries a market capitalization of 31.40B, placing it among publicly traded companies globally. Its enterprise value stands at 12.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Kanemi Co., Ltd.'s next confirmed earnings release is scheduled for January 12, 2027.

As of August 31, 2024, Kanemi Co., Ltd. has 9.68M shares outstanding.

As of August 31, 2024, Kanemi Co., Ltd. trades at a trailing price-to-earnings ratio of 17.34. The price-to-sales ratio is 0.35, and the price-to-book ratio stands at 1.10.

As of August 31, 2024, Kanemi Co., Ltd. trades at an EV/EBITDA multiple of 4.11 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 4.11 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 12.71B versus a market cap of 31.40B, with the gap driven by net debt and cash on the balance sheet.

As of August 31, 2024, Kanemi Co., Ltd. maintains a current ratio of 2.89, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended August 31, 2024, Kanemi Co., Ltd. posted a return on equity (ROE) of 6.53, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.84 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.88, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.53, useful for judging operating efficiency across full business cycles. The company generates approximately 78.21M in revenue per employee across its workforce of 1,145.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 144.42 indicates how many times Kanemi Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended August 31, 2024, Kanemi Co., Ltd. recorded 1.04B in income tax expense. That works out to an effective tax rate of 36.38, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.85B, leaving 1.81B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Kanemi Co., Ltd.'s stock has gained approximately 16.14% over the past 52 weeks. The 50-day moving average sits at 3,930.90, while the 200-day moving average is 3,758.45.

Over the twelve months ended August 31, 2024, Kanemi Co., Ltd. generated 89.55B in revenue and converted that into 1.81B in net income, yielding earnings per share of 187.18. EBITDA reached 3.10B, while operating income came in at 3.10B.

As of August 31, 2024, Kanemi Co., Ltd. holds 18.70B in cash and equivalents against 15.25M in total debt, resulting in a net debt position of -18.70B. Total book value stands at 28.49B, with working capital of 17.89B providing operational flexibility.

Over the twelve months ended August 31, 2024, Kanemi Co., Ltd. posted a gross margin of 17.26, reflecting its pricing power and cost economics. The operating margin of 3.46 and net profit margin of 2.02 provide insight into operational efficiency.

Kanemi Co., Ltd.'s most recent stock split took place on March 26, 2004 with a 10:11 split ratio.

As of August 31, 2024, Kanemi Co., Ltd. has an Altman Z-Score of 5.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.